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Abstract
Introduction: Prader-Willi Syndrome (PWS) is a genetic disorder caused by the lack of expression of certain
paternal genes located on chromosome 15q11-q13. This anomaly causes cognitive, neurological and endocrine
abnormalities, among which one of the most important is hyperphagia. The aim of this study was to assess the oral
health of children with PWA and to establish preventive criteria.
Results: Thirty patients with PWS (mean age 10.2 years) and 30 age- and gender-matched controls were included
in the study. Twenty-six patients with PWS(86.6%) followed dietary treatment prescribed by their endocrinologist.
Individuals with PWS had a mean caries index of 53.3% and Decayed Missing Filled teeth (DMFT) index 2.5, and
53.3% had gingivitis, in the control group the respective figures were 43.3%, 0.93, and 60%. Only the DMFT index (p
0.017) presented significant differences. Regarding stimulated salivary secretion, patients with PWS presented a
mean of 0.475 ml/min with a pH of 6.15, while controls presented a mean of 0.848 ml/min with a pH of 7.53; the
differences between the groups were statistically significant in both cases (p 0.032 and p 0.0001 respectively). The
population with PWS presented a higher plaque index (> 2) than their healthy peers, but the differences were not
significant.
Conclusion: Pediatric patients with Prader-Willi syndrome have an increased risk of caries and gingivitis. The
children with this syndrome have a decreased salivary flow and a more acidic salivary pH. In these patients, dental
care is an essential part of their multidisciplinary medical treatment.
Keywords: Prader-Willi syndrome (PWS), Hyperphagia, Salivary alteration, Plaque index (PI), Caries index (CI)
Introduction
The condition now known as Prader-Willi Syndrome
(PWS) was first described by Langdon-Down in 1887, and
the term Prader Labhart Willi Syndrome (later shortened
to Prader-Willi Syndrome) was coined by Prader, Labhart
and Willi in 1956 [1–5]. Currently, most authors agree
that PWS is a complex multisystemic genetic disorder
caused by the lack of expression of certain paternal genes
located on the chromosome 15q11-q13 [4, 6, 7].
In 1981, Ledbetter demonstrated that most patients
with PWS had an interstitial deletion of the proximal
long arm of chromosome 15 at region q11–q13. Conse-
quently PWS was described as one of the first examples
of an error in genomic imprinting (GI) in humans. GI is
a molecular process by which some genes are not
expressed, due to the carrier parent. It is an epigenetic
phenomenon in which the phenotype is modified de-
pending on the mono-allele gene that is inherited from
one of the parents. Therefore, the printing marks the
genes in such a way that the origin of the two copies can
be distinguished, with one parent’s copy being activated
and the other’s copy silenced [8–10]. In the case of
PWS, the process depends on the father, there is a frag-
ment of the father’s chromosome 15q that is imprinted,
that is to say, silenced, and so it is not expressed [9–11].
There are three genetic subtypes of PWS, whose com-
mon feature is the loss of expression of genes located at
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the 15q11-q13 locus. In descending order of frequency,
these subtypes are: the deletion (DEL) of the 15q11-q13
region of paternal origin in about 65% of cases; maternal
uniparental disomy (MUD) in about 30%, in which the
individual presents two copies of the maternal chromo-
some 15; an imprinting center defect in less than 5% and
rare cases of translocation involving the chromosome
15q11-q13 region [10]. This genetic anomaly leads to a
pattern of physical characteristics with cognitive, neuro-
logical and endocrine abnormalities that change over the
course of the patient’s life [12].
So PWS is a rare genetic disorder that can affect any
race and sex [5, 8, 12–14] and has an estimated prevalence
of 3.1: 100000 live newborns in Europe [15]. With regard
to the patient’s eating habits, it is characterized by two
stages. Newborns present severe hypotonia (Fig. 1), global
developmental delay and lack of appetite. As a result they
have difficulty gaining weight, and in most cases, feeding
via nasogastric tube is necessary [4, 6, 13]. The second
stage begins during early childhood; it is characterized by
an eating disorder known as hyperphagia, which favors
overweight and obesity [4, 6, 13, 16, 17].
In fact, PWS is the genetic syndrome most commonly
associated with obesity, and its complications decrease
life expectancy [4, 6, 9, 18, 19]. Apart from hyperphagia,
patients also have a malfunctioning hypothalamus. The
hypothalamus is a part of the brain that is responsible
for integrating the nervous and endocrine systems
which, together with the pituitary system, regulate as-
pects of growth, development, metabolism and homeo-
stasis. Its main functions are the control of the
autonomic nervous system by regulating visceral activity
and the secretion of several glands; the production of
hormones such as the growth hormone; the regulation
of emotions, memory and behavior; the regulation of ap-
petite; control of body temperature, and regulation of
the heart rate and states of consciousness [20].
As a result, hypothalamic alterations can cause intel-
lectual disability, behavioral problems, thermoregulatory
dysfunction, a high pain threshold, respiratory sleep dis-
orders, hypopigmentation, hypogonadism, pubertal delay
and infertility, short stature, and small hands and feet
(Fig. 2) [8, 21].
As for the facial phenotype, patients with PWS usually
present a narrow forehead, elongated almond-shaped
eyes with ascending oblique palpebral fissures, and a tri-
angular mouth with commissures facing downwards and
thin upper lip [1, 22–24].
The dietary problems associated with this general sys-
temic condition increase the risk of oral pathology. It
has been observed that patients with PWS are at greater
risk of suffering oral diseases such as enamel hypoplasia,
caries, tooth wear caused by attrition, erosion or abra-
sion, periodontal disease, delayed tooth eruption, candid-
iasis, oral lesions and decreased salivary flow (Fig. 3) [1,
18–20, 22, 24–26].
The Prader-Willi syndrome is characterized by low
salivary quantity and quality due to atrophy of the saliv-
ary glands, which in turn is due to the low birth weight.
Increased amounts of salivary ions and proteins make
Fig. 1 Hypotonia in a newborn with PWS Fig. 2 Physical characteristics of PWS
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the saliva sticky, sparse and unable to perform its func-
tions (Fig.4) [25, 27, 28]. The enamel hypoplasia may be
caused by malnutrition and low birth weight, and is as-
sociated with the first phase of the syndrome [27, 29]. In
addition, the combination of the lack of oral hygiene, re-
duced salivary flow and the preference for foods high in
carbohydrates raises the risk of caries and gingivitis [18,
19, 24, 30]. These alterations in the oral cavity may be
aggravated by the hypotonia which hinders suction,
swallowing and chewing and makes the introduction of
a soft diet mandatory [25].
The aim of this case-control study was to evaluate the
oral conditions of children with Prader-Willi syndrome
and to establish a prevention protocol for these patients.
Materials and methods
A cross-sectional observational case-control study was
designed and carried out between 2016 and 2017, in
which 60 participants from the Sant Joan de Déu Hos-
pital were enrolled: 30 patients with PWS (cases) and 30
age- and gender-matched healthy patients (controls).
Participants’ socio-demographic variables were re-
corded in a questionnaire. The nature of the study
was explained to the parents or guardians who pro-
vided signed informed consent, prior to their chil-
dren’s enrolment. If a child was following a medically
prescribed diet, this was recorded. Both the oral
examination and the salivary sampling were carried
out in the dental office.
The type of dentition of each patient was registered
and classified into deciduous, mixed or permanent. Sub-
sequently, the Decayed Missing Filled teeth (DMFT)
index was calculated for each individual and the accu-
mulation of plaque was estimated using the Silness and
Löe plaque index [31]: 0- No plaque in the gingival area;
1- A film of plaque adhering to the free gingival margin
and adjacent area of the tooth. The plaque may be seen
in situ only after application of disclosing solution or by
using the probe on the tooth surface; 2- Moderate accu-
mulation of soft deposits within the gingival pocket or
the tooth and gingival margin, visible with the naked
eye; and 3- Abundance of soft matter within the gingival
pocket and/or on the tooth and gingival margin.
The presence or absence of gingival inflammation
(gingivitis) was evaluated using the Löe and Silness
gingival index [32]: 0- Normal gingiva, no inflamma-
tion, no change of color, no bleeding; 1- Mild inflam-
mation, slight change in color, slight edema, does not
bleed when probing; 2- Moderate inflammation, red-
ness, edema and glazing, bleeding on probing and
pressure; and 3- Severe inflammation, marked redness
and edema, ulceration with tendency to spontaneous
bleeding.
Finally, tests were carried out to quantify salivary pH.
To obtain the saliva, we used the GC Saliva Check Buffer®
Kit, a test specifically designed to assess saliva volume.
Each patient was asked not to eat for two hours and to
chew a paraffin tablet for two minutes and the volume of
Fig. 3 a.b/ Deciduous dentition. Observe the areas of attrition with severe incisal wear, and erosions present in vestibular areas; c/ Deciduous
dentition. Dental malocclusion with anterior crossbite in the incisor region
Fig. 4 PWS patients present thickened, sticky saliva. See the clinical manifestations in the images
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stimulated saliva was recorded, considering a value of 1.2
ml/min to be normal. Once this process was complete,
saliva pH was measured by applying a drop of saliva on
top of a Lyphan® test strip (Neuhaus, Germany). A score
between 6.75 and 7.25 was considered normal.
After obtaining the results, the descriptive statistics of
the study sample were recorded. The between-groups
comparisons were made by means of the Chi-square test
for qualitative variables and the Student’s t-test and
Spearman’s rho for quantitative variables, accepting a p
level < 0.05 as significant.
Results
Of 43 patients genetically diagnosed with PWS at the
Sant Joan de Déu Hospital, 30 were attended at the den-
tistry. All of them received growth hormone treatment.
Both case and control populations consisted of 12 fe-
males and 18 males, with a mean age of 10.2 years (range
2–18 - SD 5.314). Twenty-six patients with PWS (86.6%)
were receiving low calorie and low sugar dietary treat-
ment in order to avoid obesity and its possible
consequences.
Dentition was deciduous in 20% of the cases, mixed in
46.7% and permanent in 33.3%; in the control group the
figures were 26.7, 40.0 and 33.3% respectively. Patients
with PWS had a caries index of 53.3% and a DMFT of
2.5 (SD 3.170), and 16 (53.3%) had gingivitis. The
controls had a caries index of 43.3% and a DMFT of
0.93 (SD 1.311), and 12 (40%) had gingivitis. About 70%
of the population with PWS had a higher plaque index
(grade > 2) than controls, of whom 56% presented mild
plaque (grade < 1). PWS presented stronger associations
with clinical gingivitis than controls, but the differences
were not significant. Other findings identified during the
bucodental examination in the PWS group were dental
erosion, attrition or wear in nine (30%), angular cheilitis
in three, and enamel hypoplasia in only two. In the
group of healthy patients only three presented attrition
or wear, and none presented angular cheilitis/oral le-
sions (Table 1).
In the tests to determine the quantity of stimulated
saliva in ml/min and the pH, not all the participants
were able to cooperate fully, due to intellectual disability
in some cases and young age in others. Greater cooper-
ation was obtained from healthy patients than from pa-
tients with PWS. Regarding stimulated saliva, the mean
volume for cases was 0.475 (SD – 0.571) ml/min with a
mean pH of 6.15 (SD – 0.818), compared with figures of
0.848 ml/min (SD – 0.493) and 7.53 (SD – 0.776) re-
spectively in the controls (Table 2).
The between-group comparison revealed statistically
significant differences both in the DMFT index (p 0.017)
and in the quantification of ml/min (p 0.032) and pH of
the saliva (p 0.0001): PWS cases presented lower salivary
Table 1 Descriptive statistics of the oral conditions in the sample
Parameters PWS n (%) Control n (%)
Sex Male 18 (60%) 18 (60%)
Female 12 (40%) 12 (40%)
Age Mean age (years) 10.2 years (range 2 to18 - SD 5.314)
Type of dentition Deciduous n (%) 6 (20.0%) 8 (26.7%)
Mean age 3.16 3.87
Mixed n (%) 14 (46.7%) 12 (40.0%)
Mean age 8.66 9.5
Permanent n (%) 10 (33.3%) 10 (33.3%)
Mean age 16.2 16.1
Plaque Index 0 3 (10.0%) 2 (6.7%)
1 6 (20.0%) 15 (50.0%)
2 14 (46.7%) 8 (26.7%)
3 7 (23.3%) 5 (16.6%)
Gingival Index 0–1 14 (46.7%) 18 (60.0%)
2 16 (53.3%) 12 (40.0%)
3 0 0
Dental erosion, attrition or wear 9 (30.0%) 3 (10.0%)
Enamel hypoplasia 2 (6.7%) 0
Angular cheilitis-oral lesions 4 (13.3%) 0
Candidiasis 0 0
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flow, a more acidic pH and a higher DMFT index than
controls (Table 2). Comparing the DMFT index versus
stimulated saliva, saliva pH and the plaque index, the
only statistically significant differences were observed in
healthy individuals between the DMFT (0.93) and saliva
pH (7.53). With more alkaline pH, the controls’ caries
indices were lower (p < 0.05) (Table 3).
Discussion
PWS is a genetic alteration that causes a hypothalamic
dysfunction, which manifests itself in the form of physical,
neurological and endocrine disorders, above all hyperpha-
gia. Several hypotheses have been proposed regarding the
eating disorders associated with the syndrome. McAllister
et al. (2011) suggested that during the first years of life in
these patients an excess of leptin, a satiating hormone,
may favor poor feeding. At later ages, ghrelin, an appetite-
regulating hormone, may be involved in the development
of hyperphagia. PWS seems to be related more to the lack
of satiety than to the feeling of hunger [17]. Because of
their lack of control over feeding, patients must follow a
strict fiber-rich diet (1100-1200Kcal) monitored by an
endocrinologist [4, 6, 26].
PWS is a rare disease, most of the studies of the syn-
drome published to date are clinical case reports, and few
studies have been carried out with large samples. At our
institution we were able to group together a relatively
large sample of patients under the “Prader Willi functional
plan”, in which different services perform clinical controls
of these patients at the same time and on the same day.
For this reason, we were able to study a range of variables
that provided us with a broad overview of the oral-dental
health status of patients with PWS.
Due to the patients’ general state of health the risk of
caries is high, even during the first year of life. Patients
should be referred to the pediatric dentist, and periodon-
tal prophylaxis should be performed every 3–4 months
[33]. Several authors attribute the increased incidence of
caries to poor oral hygiene and increased frequency of
food consumption, in combination with alterations in
saliva (in terms of quantity and viscosity) [18–20]. In an
acidic environment, tooth enamel undergoes a process
of demineralization which increases the risk of tooth
decay. Saliva flow after food intake helps increase plaque
pH, which has previously fallen due to the exposure to
sugars and carbohydrates in the diet [34].
However, Saeves et al. (2012) found no significant dif-
ference between the risk of caries in individuals with
PWS and in healthy patients [22]. In the present study,
no significant differences were found regarding the car-
ies indices between the populations, though caries were
more frequent in individuals with PWS. In comparison
to PWS patients, cerebral palsy patients of a similar age
treated at our pediatric dentistry department presented
lower scores on the DMFT index (2.8) and the plaque
index (70% grade 3) and lower rates of gingivitis (80%
moderate-severe).
According to Dougall and Fiske (2008) the poor oral
hygiene of patients with PWS predisposes them to oral
diseases [19]. Even so, recent research has reported an
improvement of oral hygiene compared with earlier
studies [4, 6]. With regard to periodontal disease, in a
clinical case study of periodontitis in Prader-Willi Syn-
drome Yanagita M et al. (2011) concluded that peri-
odontal loss was a consequence of the combination of
dental malocclusion, occlusal trauma and poor plaque
control. In addition, the interaction of multiple affected
genes in PWS and a growth hormone deficiency may
alter the immune response and increase susceptibility to
periodontal destruction [24, 35]. The dental examination
performed in the present study did not identify peri-
odontitis in any of our patients, all of whom were treated
with growth hormone.
Olczak-Kowalczyk D et al. (2019) showed that the
mean gingival index values in PWS patients with mixed
dentition, were significantly higher than in the control
group, but the mean plaque index values were not [36].
In our sample there were more cases of gingivitis in pa-
tients with PWS than in their healthy peers, but the dif-
ferences were not statistically significant.
Most authors agree that patients with PWS present re-
duced salivary flow. Saeves et al. (2012) suggest that the
secretion of proteins in the salivary glands may be func-
tioning well or may even be overexpressed, but that the
reduction in flow affects both the quality and the
Table 2 Comparison of stimulated salivary flow, pH and DMFT
in the two populations
GROUP n Mean SD P value
ml/min PWS 18 0.475 0.5714 0.032
Control 25 0.848 0.4932
pH PWS 27 6.15 0.818 0.0001
Control 30 7.53 0.776
DMFT PWS 30 2.5 3.170 0.017
Control 30 0.93 1.311
p < 0.05. Student t-test
Table 3 Comparison of DMFT index and pH
DMFT and pH in healthy patients Correlation coefficient 0.373*
Significance (two-sided) 0.042
n 30
DMFT and pH in patients with PWS Correlation coefficient −0.150
Significance (two-sided) 0.455
n 27
p < 0.05 (Spearman’s Rho test)
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amount of saliva [22, 23]. Although patient cooperation
was a limitation for obtaining saliva, we found that the
saliva of patients with PWS was more viscous and thick.
Some researchers have reported that the type of saliva of
these patients, with reduced flow rate and molecular and
ionic changes, is incapable of remineralizing the enamel
and, therefore, promotes excessive tooth wear and in-
creases the risk of cavities [28, 37]. Olczak-Kowalczyk D
et al. also confirmed worse physical and chemical parame-
ters of saliva in subjects with PWS compared to the con-
trol group. They found a negative correlation between the
age of PWS patients and watery consistency of saliva, and
suggested that salivary viscosity may increase with age
[36]. As we mentioned above, the difficulty of obtaining
saliva in some non-collaborative patients meant that our
study lacked the statistical power needed to carry out an
in-depth analysis of this correlation between age and saliv-
ary viscosity. It has also been observed that inadequate sal-
ivary secretion may increase susceptibility to infections or
lesions in the oral mucosa, and may increase the accumu-
lation of dental plaque [20, 38]. Even so, a study of saliva
and dental caries concluded that there was little associ-
ation between values of salivary secretion and the inci-
dence of caries [39]. Although the methods we used to
obtain saliva were different from those used by González
et al. (2008) [25] and Saeves et al. (2012) [23], our stimu-
lated salivary secretion level was markedly lower than the
value stipulated as normal (1.2ml/min). In addition, our
mean pH (6.15) was slightly more acid than normal (6.75–
7.25) [40].
To be able to provide dental treatment for patients
with PWS and to obtain good levels of oral hygiene,
their ability to cooperate must be evaluated. A thorough
clinical history must be obtained and the presence of
oral diseases assessed [18]. To maintain adequate oral
hygiene, Dougall and Fiske note the usefulness of draw-
ings and posters with written text, because individuals
with PWS have good visual ability [19]. The application
of topical fluoride gels or daily rinses is recommended
and frequent preventive dental appointments should be
scheduled [19]. Other authors affirm that patients able
to cooperate can undergo dental procedures under local
anesthesia; due to patients’ poor muscle control, they
recommend the use of mouth openers [18]. Several re-
searchers stress the importance of an early diagnosis, the
observation of basic prevention guidelines from the first
year of life, and a multidisciplinary approach to the dis-
ease so as to improve quality of life [4, 6, 8, 10, 30, 33].
Within the multidisciplinary team, the role of the pediatric
dentist is essential for the management and establishment of
oral prevention guidelines for children with PWS. It is im-
portant to coordinate the appointments with different spe-
cialists on a single day, so as not to disrupt families’ daily
routines and to avoid multiple hospital visits. The protocol
described in this study was designed by a committee of ex-
perts from the same hospital and was led by the endocrin-
ology team. Other services such as genetics, neurology,
traumatology, ophthalmology psychology, gastroenterology,
pulmonology and dentistry, coordinated periodical visits
every 6–12months.
Conclusions
Pediatric patients with Prader-Willi syndrome have a
higher risk of cavities and gingivitis than the general
population. Children with this syndrome have decreased
salivary flow and a more acid salivary pH.
Although several hypotheses have been put forward
regarding the eating disorders associated with this syn-
drome, it is important to continue the study of the pro-
cesses that hinder the control of hyperphagia and the
impact of this eating disorder on oral health.
Finally, Prader-Willi syndrome is associated with an
increased risk of certain oral-dental diseases in pediatric
ages. Establishing a prevention protocol that enables
pediatric dentists to provide dental care at very early
stages of life is an essential component of the multidis-
ciplinary therapeutic approach in these patients.
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